L David Wise (David Wise)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Venues

Birth defects research

Birth defects research. Part A, Clinical and molecular teratology

Merck & Co., Inc.

University of Cincinnati (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Merck & Co., Inc. Mar 06 1985 - Nov 08 2013

United States

Distinguished Senior Investigator :: Safety Assessment

Education History

University of Cincinnati

United States

PHD

Publications

L David Wise, John M DeSesso
Comments on "Maternal-fetal safety evaluation of an aqueous extract of Casearia sylvestris [AECS] leaves in rats" (Nagaoka et al., 2023 [DOI: 10.1002/bdr2.2257]). Birth defects research 116 (3) (2024)
L David Wise
Rodent anogenital distance recommendations. Birth defects research 116 (6) (2024)
L David Wise, John M DeSesso
Comments on "Maternal-fetal safety evaluation of an aqueous extract of Casearia sylvestris [AECS] leaves in rats" (Nagaoka et al., 2023 [DOI: 10.1002/bdr2.2257]). Birth defects research 116 (3) (2024)
L David Wise
Rodent anogenital distance recommendations. Birth defects research 116 (6) (2024)
L David Wise, Stephen B Harris, William S Webster, John M DeSesso
Recommendation to change the peer review process. Birth defects research (2023)
L David Wise, John M DeSesso
A critical look at adjusted fetal weights in rats. Birth defects research (2023)
L David Wise, Lori A Dostal, John M DeSesso
Comments on "The teratogenic effects of sertraline in mice" (Cabrera et al., 2020 [DOI: 10.1002/bdr2.1660]). Birth defects research 112 (13) (2020)
L David Wise
Comments on "Reproductive toxicology studies supporting the safety of molindone, a dopamine receptor antagonist" (Gopalakrishnan et al., Birth Defects Research. 2018; 110(16):1250-1262). Birth defects research 111 (4) (2019)
L David Wise
Comments on "Embryo-fetal development studies with the dietary supplement vinpocetine in the rat and rabbit" (Catlin et al. Birth Defects Research. 2018, 110, 883-896). Birth defects research 110 (18) (2018)
L David Wise
Letter to the editor: Comments on venlafaxine paper by Laurent et al. Birth defects research. Part A, Clinical and molecular teratology 106 (12) (2016)

L David Wise.css-eqlu8i{font-size:small;padding-left:4px;} (David Wise)

Publication Activity (10 Years)

Top Topics

Top Venues

L David Wise (David Wise)